HDACis inhibit the activity of cancer stem cells by targeting several essential genes involved in cancer stem cell maintenance, such as those encoding β, γ-catenin, Stat3, and Notch1, thereby reducing tumor development [83]. Here, NOTCH1 is linked to cancer.